The criterion for the diagnosis of the disseminated intravascular coagulation syndrome (DIC) established by the Ministry of Health and Welfare of Japan was subjected for evaluation in patients with DIC associated with hematopoietic tumors (375) and non-hematopoietic tumors (551). Bleeding was frequent in the DIC group (>60%) and organ failures were frequently observed in the group of patients with non-hematopoietic tumors. Regardless of hematopoitic or non-hematopoitic tumors, differences of the prothrombin time (PT) ratio and those of plasma fibrinogen were found to be highly significant between the DIC and non-DIC patient groups (p<0,001). The difference of the fibrinogen/fibrin degradation products (FDP) between the two groups was only slightly significant, however (p<0,05), FDP appeared to be the highest but the plasma fibrinogen was the lowest in terms of the sensitivity for the diagnosis of DIC, whereas the plasma fibrinogen was the highest and FDP was the lowest in terms of its specificity. The receiver operating characteristic analysis showed that FDP, the PT ratio, platelet counts and plasma fibrinogen were useful for the diagnosis of DIC in this order. To elevate the cut-off value of FDP and to reduce that of the PT ratio thus seem to be more efficient for the diagnosis of DIC.
View full abstract